REMI-AI Rapid Detection Module (REMI-AI RDM)
Overview
The REMI-AI Rapid Detection Module (REMI-AI RDM) by Epitel is an FDA-cleared artificial intelligence (AI) tool designed for the near real-time detection of electrographic seizures. Integrated into the broader REMI Remote EEG Monitoring System, REMI-AI RDM leverages a cloud-based wearable sensor system and advanced AI technologies to provide accessible and reliable brain health insights. The system utilizes disposable, wireless EEG sensors that can be easily applied, even by non-EEG technicians, to capture high-fidelity EEG recordings for extended durations, up to 30 days.
REMI-AI RDM conducts automated analysis of EEG data and provides notifications to qualified clinicians regarding the prevalence and confidence of potential electrographic seizures, specifically when a combined prevalence of 10% or greater (indicating at least 30 seconds of activity) is detected within a rolling 5-minute window. These notifications are delivered through the REMI Mobile software application, which also facilitates data transmission to the secure REMI Cloud for storage and review on qualified EEG viewing software. The tool is intended for use in non-ICU healthcare settings for adult and pediatric patients (6+ years), aiming to reduce delays in seizure identification and improve patient outcomes.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Automated analysis of EEG data
- Near real-time electrographic seizure detection
- Notifications of potential electrographic seizures with confidence levels and prevalence
- Integrated with REMI Remote EEG Monitoring System
- Wearable, wireless EEG sensors (part of the REMI system)
- Cloud-based data analytics and storage
- Mobile application for notifications and data transmission (REMI Mobile)
- High-fidelity EEG recordings
- Easy application by non-EEG technicians
- Supports extended monitoring duration (up to 30 days for REMI system)
Use Cases
- Electrographic seizure detection in non-ICU healthcare settings
- Remote EEG monitoring in healthcare facilities
- Ambulatory (at-home) EEG monitoring (as part of the REMI system)
- Assisting qualified clinicians in assessing EEG records
- Improving diagnosis, treatment, and management of seizures
- Rapidly deployable triage tool for seizure detection in emergency rooms
What Physicians Need to Know
REMI-AI RDM is an assistive tool for EEG review, not a standalone diagnostic. Physicians should exercise professional judgment in interpreting the AI's notifications, which include prevalence and confidence levels for potential electrographic seizures. The system is validated for non-ICU and ambulatory settings and is not indicated for detecting electrographic status epilepticus. Be aware that notifications may have a delay of several minutes, so it should not replace real-time monitoring. Its utility is particularly strong for extended monitoring to capture infrequent seizure events.
The REMI system, including REMI-AI RDM, integrates with the REMI Mobile software application, which transmits data to a secure REMI Cloud. The data is then prepared for review on qualified EEG viewing software, notably Persystu2122 Mobile, a widely used EEG monitoring platform. The system communicates wirelessly via Bluetooth with its sensors and requires a secure WiFi connection for the REMI tablet.
Details
| Category | Neurology AI, Wearables & Remote Monitoring (RPM) |
| Pricing | Contact for pricing |
| Deployment | Cloud-based, with wearable sensors and mobile application. |
| Compliance | |
| BAA Available | Yes AI-estimated |
| HIPAA Compliant | Yes AI-estimated |
| FDA Status |
Yes AI-estimated The REMI-AI Rapid Detection Module (REMI-AI RDM) (K240408) is a seizure detection module integrated into the REMI Remote EEG Monitoring System. It was cleared by the FDA on October 17, 2024, and is indicated for use in non-ICU healthcare settings for adult and pediatric patients (6+ years) to provide notifications of potential electrographic seizures with a combined prevalence of 10% or greater within a rolling 5-minute window of EEG. |
| Integrations | |
| EHR | Not specified |
| Specialties | Emergency Medicine, Hospital Medicine, Neurology |
What the Web Says
The REMI-AI Rapid Detection Module (REMI-AI RDM) is an AI-powered seizure detection module integrated into Epitel's REMI Remote EEG Monitoring System. It is designed for use in non-ICU healthcare settings and analyzes EEG data in near real-time to provide notifications of potential electrographic seizures. The system aims to make EEG monitoring more accessible and efficient, particularly in facilities without 24/7 EEG coverage or specialized technicians. The device is intended to assist qualified clinicians in their review of EEG records, rather than providing a diagnostic conclusion itself.
Overall: PositiveStrengths
- Automated, near real-time detection of potential electrographic seizures.
- Increases accessibility of EEG monitoring in non-ICU settings and facilities lacking specialized staff.
- Wireless system allows patients to move freely and can be used for extended durations (up to 30 days).
- Annotates EEG records with detected events, confidence levels, and duration to aid physician review.
- FDA 510(k) cleared with a Predetermined Change Control Plan (PCCP), allowing for performance-enhancing updates without additional FDA review.
- Can be initiated quickly and is reimbursable using existing codes.
Limitations
- Not indicated for use in ICUs or for the detection of electrographic status epilepticus.
- Notifications are not a substitute for real-time EEG monitoring by a trained expert.
- Does not provide diagnostic conclusions or make treatment recommendations.
- Delays of up to several minutes can occur between event detection and notification.
- Some neurologists have expressed skepticism about machine learning in EEG interpretation.
- Lower channel count compared to traditional EEG systems, which may limit spatial coverage for seizure onset zone localization.
Based on reviews from: accessdata.fda.gov, BioUtah, PMC, Practical Patient Care, YouTube, Neurology Today, BioSpace
Last updated: 2026-07-18
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate REMI-AI Rapid Detection Module (REMI-AI RDM)
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for REMI-AI Rapid Detection Module (REMI-AI RDM).
Frequently Asked Questions
Investors who backed REMI-AI Rapid Detection Module (REMI-AI RDM)
Funded through the company that built this tool.
